- McDonald's has raised its dividend for 49 consecutive years, although CEO Christopher Kempczinski acknowledged that execution has been inconsistent across the system.
- Johnson & Johnson aims to grow its oncology business from $30 billion to $50 billion by 2030, positioning itself as the largest player in the sector.
- The U.S. Census Bureau reports that, as of July, residential housing starts and completions are both now near or at multiyear lows, with a need for an additional 4-5 million homes to meet actual demand.
- Average and median home prices in the U.S. have been drifting lower for three years, according to the Census Bureau and U.S. Department of Housing and Urban Development.
- Recently, the FDA cleared the latest version of the software used by Johnson & Johnson's robotically assisted bronchoscopy platform called the Monarch, marking the fourth launch in a year and a half.
Investors are increasingly turning to high-yield dividend stocks as a strategy for retirement, particularly those offering yields around 9% with consistent payout growth.
Companies like McDonald's and Johnson & Johnson stand out in this category, with McDonald's boasting a dividend that has been raised for 49 consecutive years.1234
The fast-food giant's dividend growth is supported by a robust cash flow model, primarily derived from franchisee rent, ensuring stability regardless of restaurant performance.
Meanwhile, Johnson & Johnson is on a trajectory to expand its oncology business significantly, aiming to grow from $30 billion to at least $50 billion by 2030. This growth is fueled by a combination of new treatment approvals and strategic acquisitions, enhancing its revenue potential.
As the market for high-yield investments becomes more competitive, 9% yields that also grow their payouts regularly are hard to find, making these companies particularly appealing for those looking to secure their financial future.
Investors should remain aware of the risks associated with high-yield investing, but the potential for substantial returns through cash flow remains a compelling reason to consider these stocks for retirement portfolios.
“McDonald's has raised its dividend for 49 straight years, with cash flow from franchisee rent supporting the streak. Johnson & Johnson aims to grow its oncology business from $30 billion to $50 billion by 2030, with Darzalex revenue up 19% in Q2.”
Seeking Alpha
